Midatech’s management is supported by a strong board of directors composed of individuals from various industries as well as academia. The breadth and depth of its members’ experience in medicine, pharmaceuticals, venture capital, strategy and general management is instrumental in providing advice and leadership to the Company.
CEO of Many More Homes Limited; developed several landmark properties in London, including Broadgate and the Paddington Basin; leader of various charitable organizations including Chairman of Friends of the Earth Trust and founder of the Campaign for Freedom of Information, among others.
Professor Fritz Bühler
Professor Emeritus of Pharmaceutical Medicine, Pathophysiology, Internal Medicine and Cardiology at Basel University; Coordinator of the European Innovative Medicine Initiative; former partner of two Healthcare Venture funds; former head of Global Clinical R&D and Chief Medical Officer at Hoffmann-La Roche.
CEO and founding member of Brown Equity Partners; former founding partner of Forrest Binkley & Brown; former Senior Vice President of Bank of America Venture Capital Group; former Senior Vice President of Security Pacific Capital Corporation.
Managing Director at Pell Frischmann Group; former Managing Director at European Land; former solicitor with Linklaters.
Keith J. Kendall
Non-Executive Director; Member Audit Committee
Co- President and Chief Operating Officer of MonoSol Rx; former Vice President and Managing Director for Hewlett Packard Financial Services; former President of AT&T Credit Corporation and NCR Credit Corporation.
Sir David King
Chief Scientific Advisor to H.M. Government under Tony Blair and Gordon Brown; former head of the Government Office for Science; Director at the Universities of Oxford and Cambridge; Adviser on African Development to the European Commissioners; Senior Science Adviser to UBS.
Partner at Bain & Co; Bain Head of European Media, Telecommunication and Technology Practice; member of Bain & Co’s worldwide Board of Directors.
Non-Executive Director, Member Remuneration and Audit Committees
Non-executive director of two banks; Former partner at BDO Stoy Hayward; advisor to the board of a US gaming and entertainment company.
Professor Thomas Rademacher
Chairman of the Board of Directors
See Management Team
See Management Team
Sijmen de Vries
Non-Executive Director; Member of Remuneration Committee
CEO of Pharming N.V.; former CEO of 4-Antibody AG; former CEO of Morphochem AG; former member of the executive board of Biovertis AG; former head of Global Business Development for Novartis.